Literature DB >> 3039464

The human beta-globin gene contains a downstream developmental specific enhancer.

G Kollias, J Hurst, E deBoer, F Grosveld.   

Abstract

The human beta-globin gene is part of a multigene family and is expressed specifically in adult human erythroid tissue (for review, 1). When the human beta-globin is introduced into fertilized mouse eggs, it is first activated in foetal liver and remains expressed in adult erythroid tissues. It therefore mimicks the pattern of expression of its murine counterpart. It has previously been shown in tissue culture and transgenic mice that sequences downstream from the beta-globin promoter are involved in this regulation. We now show that at least part of these sequences are located 0.5-1.2kb downstream from the poly A addition site and constitute a transcriptional enhancer element that is erythroid and developmental specific.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3039464      PMCID: PMC306019          DOI: 10.1093/nar/15.14.5739

Source DB:  PubMed          Journal:  Nucleic Acids Res        ISSN: 0305-1048            Impact factor:   16.971


  28 in total

1.  Regulated gene expression in transfected primary chicken erythrocytes.

Authors:  J E Hesse; J M Nickol; M R Lieber; G Felsenfeld
Journal:  Proc Natl Acad Sci U S A       Date:  1986-06       Impact factor: 11.205

2.  Detailed analysis of the mouse H-2Kb promoter: enhancer-like sequences and their role in the regulation of class I gene expression.

Authors:  A Kimura; A Israël; O Le Bail; P Kourilsky
Journal:  Cell       Date:  1986-01-31       Impact factor: 41.582

3.  Mechanisms that regulate immunoglobulin gene expression.

Authors:  K L Calame
Journal:  Annu Rev Immunol       Date:  1985       Impact factor: 28.527

4.  Cell-specific expression of the rat insulin gene: evidence for role of two distinct 5' flanking elements.

Authors:  T Edlund; M D Walker; P J Barr; W J Rutter
Journal:  Science       Date:  1985-11-22       Impact factor: 47.728

5.  The sequence of the chromosomal mouse beta-globin major gene: homologies in capping, splicing and poly(A) sites.

Authors:  D A Konkel; S M Tilghman; P Leder
Journal:  Cell       Date:  1978-12       Impact factor: 41.582

6.  Hybridization of a myeloid leukemia-derived human cell line (K562) with a human Burkitt's lymphoma line (P3HR-1).

Authors:  G Klein; J Zeuthen; I Eriksson; P Terasaki; M Bernoco; A Rosén; G Masucci; S Povey; R Ber
Journal:  J Natl Cancer Inst       Date:  1980-04       Impact factor: 13.506

7.  An embryonic pattern of expression of a human fetal globin gene in transgenic mice.

Authors:  K Chada; J Magram; F Costantini
Journal:  Nature       Date:  1986 Feb 20-26       Impact factor: 49.962

8.  Embryonic erythroid differentiation in the human leukemic cell line K562.

Authors:  T Rutherford; J B Clegg; D R Higgs; R W Jones; J Thompson; D J Weatherall
Journal:  Proc Natl Acad Sci U S A       Date:  1981-01       Impact factor: 11.205

9.  The DNA sequence of the H-2kb gene: evidence for gene conversion as a mechanism for the generation of polymorphism in histocompatibilty antigens.

Authors:  E Weiss; L Golden; R Zakut; A Mellor; K Fahrner; S Kvist; R A Flavell
Journal:  EMBO J       Date:  1983       Impact factor: 11.598

10.  Erythroid-specific expression of human beta-globin genes in transgenic mice.

Authors:  T M Townes; J B Lingrel; H Y Chen; R L Brinster; R D Palmiter
Journal:  EMBO J       Date:  1985-07       Impact factor: 11.598

View more
  71 in total

1.  Inducibility of the HS II enhancer depends on binding of an erythroid specific nuclear protein.

Authors:  P A Ney; B P Sorrentino; C H Lowrey; A W Nienhuis
Journal:  Nucleic Acids Res       Date:  1990-10-25       Impact factor: 16.971

Review 2.  Macrophage-specific gene expression: current paradigms and future challenges.

Authors:  David R Greaves; Siamon Gordon
Journal:  Int J Hematol       Date:  2002-07       Impact factor: 2.490

3.  Structure and function of the enhancer 3' to the human A gamma globin gene.

Authors:  M Purucker; D Bodine; H Lin; K McDonagh; A W Nienhuis
Journal:  Nucleic Acids Res       Date:  1990-12-25       Impact factor: 16.971

4.  Differential regulation of endogenous and transduced beta-globin genes during infection of erythroid cells with a herpes simplex virus type 1 recombinant.

Authors:  C A Smibert; J R Smiley
Journal:  J Virol       Date:  1990-08       Impact factor: 5.103

5.  A homeodomain protein binds to gamma-globin gene regulatory sequences.

Authors:  D Lavelle; J Ducksworth; E Eves; G Gomes; M Keller; P Heller; J DeSimone
Journal:  Proc Natl Acad Sci U S A       Date:  1991-08-15       Impact factor: 11.205

6.  Beta-globin enhancers target expression of a heterologous gene to erythroid tissues of transgenic mice.

Authors:  J Magram; K Niederreither; F Costantini
Journal:  Mol Cell Biol       Date:  1989-10       Impact factor: 4.272

7.  Regulated expression of the human beta globin gene in transgenic mice requires an upstream globin or nonglobin promoter.

Authors:  K P Anderson; J A Lloyd; E Ponce; S C Crable; J C Neumann; J B Lingrel
Journal:  Mol Biol Cell       Date:  1993-10       Impact factor: 4.138

8.  Spontaneous inflammatory demyelinating disease in transgenic mice showing central nervous system-specific expression of tumor necrosis factor alpha.

Authors:  L Probert; K Akassoglou; M Pasparakis; G Kontogeorgos; G Kollias
Journal:  Proc Natl Acad Sci U S A       Date:  1995-11-21       Impact factor: 11.205

9.  Beta -Globin mRNA decay in erythroid cells: UG site-preferred endonucleolytic cleavage that is augmented by a premature termination codon.

Authors:  Audrey Stevens; Yang Wang; Kirsten Bremer; Jing Zhang; Robert Hoepfner; Michael Antoniou; Daniel R Schoenberg; Lynne E Maquat
Journal:  Proc Natl Acad Sci U S A       Date:  2002-09-19       Impact factor: 11.205

10.  Human gamma- to beta-globin gene switching using a mini construct in transgenic mice.

Authors:  J A Lloyd; J M Krakowsky; S C Crable; J B Lingrel
Journal:  Mol Cell Biol       Date:  1992-04       Impact factor: 4.272

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.